Key result
Point-of-care capillary INR shows a strong negative correlation with endogenous thrombin potential in VKA patients.
Why the study?
Different INR assays may vary in their results during Vitamin K antagonist treatment, necessitating assessment of their agreement with thrombin generation.
Do different INR testing methods, including point-of-care devices, accurately correlate with thrombin generation in patients on Vitamin K antagonists?
Cross-Sectional (n=60)
No
Do different INR testing methods, including point-of-care devices, accurately correlate with thrombin generation in patients on Vitamin K antagonists?
Point-of-care INR devices show high correlation with thrombin generation, confirming their validity as an accurate alternative to laboratory INR testing for patients on Vitamin K antagonists.
Answers are grounded in this paper and cite their sources.
May support POC INR as thrombin generation surrogate in VKA patients; leaves open outcome validation before practice change.
INTRODUCTION: Vitamin K antagonist (VKA) treatment requires routine monitoring using the international normalized ratio (INR). However, different INR assays may vary in their results. The aim of this study was to assess the agreement of three different INR methods, compared with thrombin generation, in patients on VKA treatment. METHODS: Sixty patients attending the Anticoagulation Clinic at Mater Dei Hospital (Msida, Malta) for VKA monitoring between August and September 2015 were enrolled. The INR was tested using a point-of-care (POC) device (CoaguChek XS Plus, Roche Diagnostics) for both capillary and venous blood samples, a photo-optical (Sysmex CS-2100i/CA-1500, Siemens) and a mechanical clot detection system (Thrombolyzer XRC, Behnk Elektronik). All assays used human recombinant thromboplastin as reagent. Thrombin generation was performed using the calibrated automated thrombogram. RESULTS: There was a negative curvilinear correlation between the endogenous thrombin potential and different INR assays (r≤-.75) and a strong positive linear correlation between the CoaguChek XS Plus on capillary samples and the other INR methodologies (r≥.96). CONCLUSION: All different INR assays showed good correlation with the thrombin generation potential. The POC INR showed one of the highest correlation coefficients with thrombin generation, confirming the POC devices as an accurate, valid alternative to laboratory INR in VKA patients.
No takes yet. Share an insight, caveat, or question.
Riva et al. (2017) conducted a cross-sectional in Vitamin K antagonist treatment (n=60). Point-of-care INR testing (CoaguChek XS Plus) vs. Laboratory INR and Thrombin generation was evaluated on Correlation between Endogenous Thrombin Potential and CoaguChek XS Plus INR on capillary blood (r = -0.80, p=<0.001). Point-of-care INR testing using CoaguChek XS Plus on capillary blood showed a strong negative curvilinear correlation with Endogenous Thrombin Potential in patients on VKA therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: